5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial
暂无分享,去创建一个
K. Pavelka | H. Marzo-Ortega | J. Sieper | A. Kivitz | A. Stefańska | R. Blanco | H. Richards | E. Delicha | S. Rohrer | Martin Cohen